COVID-19 @ NIBIB

NIBIB's goal is to accelerate research, translation, and commercialization of technologies that will provide solutions to the COVID-19 pandemic.

NIBIB is administering the RADx℠ Tech and Advanced Technology Platforms (ATP) programs. These programs are part of the NIH RADx℠ Initiative to increase testing capacity and accessibility for SARS-CoV-2, the virus that causes COVID. In addition, NIBIB is supporting other technology development, imaging approaches, and digital platforms to address the pandemic.

Rapid Acceleration of Diagnostics (RADx℠) Tech and ATP Programs

Liberty 16

The RADx Tech and ATP programs are supporting late-stage development of innovative point-of-care, home-based tests, and clinical laboratory tests.

generic bar chart titled tests produced

Summary data on proposals submitted to the RADx℠ Tech and ATP Programs.

RADx Testing

Descriptions of innovative point of care, home-based, improved clinical laboratory tests, and testing products that are increasing the capacity of testing in the U.S.

COVID-19 Research across NIBIB

Intramural Research on COVID-19

NIBIB’s Dr. Kaitlyn Sadtler is a study lead and Principal Investigator working with NIH colleagues to test people who were infected with SARS-CoV-2 and developed antibodies but did not develop symptoms. Read more about the study.

MRI of chest with arrows pointing to points on the lungs

Learn how this collaborative network is using medical imaging and clinical data sciences to reveal unique features of COVID-19. Learn more about the project.

Videos

View videos about RADx Tech/ATP programs, interviews with the NIBIB Director and more.

Program Contacts

RADxSM Tech/ATP programmatic or technical inquiries: info.radx@poctrn.org

All other RADxSM Tech/ATP Applicants: RADxNIBIB@mail.nih.gov

SBIR/STTR Applicants: NIBIB-SBIR@mail.nih.gov

All others: COVID19NIBIB@nibib.gov

Related Resources

NIH COVID-19 website

NIBIB announces additional RADx Tech program Phase 2 awards

Learn about clinical trials for treatments and vaccines at HHS Combat COVID

Director’s Message on COVID-19

NIH COVID-19 Information for Applicants/Grantees

Media Inquiries: nibibpress@mail.nih.gov or 301-496-3500

Related News

View All News
40,000 COVID-19 At-Home-Test Kits to be Distributed in Hamilton Co.
NIBIB in the News
May 4, 2021
Chattanooga, TN (WDEF) – The Say Yes! COVID Test At-Home Challenge launched Tuesday. The Hamilton County Health Department, CDC, and National Institute of Health all collaborated for this testing challenge. Source: WDEF News 12 Now
Publication reveals essential ingredients of the groundbreaking NIH RADx national diagnostics effort
Science Highlights
April 29, 2021
word cloud
One-year into implementation of the NIH RADx initiative, the IEEE Open Journal of Engineering in Medicine and Biology has dedicated a specialissue to exploring the innovative structure and operation of the RADx Tech program.
RADx expands COVID-19 home and point-of-care testing, wastewater surveillance
Science Highlights
April 23, 2021
gloved hand placing cartridge into blue instrument
The National Institutes of Health (NIH) today announced three new contracts and one new award to an existing contract for scale-up and manufacturing of novel COVID-19 testing technologies.
Update: Hamilton County Health Dept. offers free rapid at-home COVID-19 testing kits in new challenge
NIBIB in the News
April 23, 2021
Update: The Hamilton County Health Department launched a new initiative to tackle the asymptomatic spread of COVID-19. The "Say Yes! COVID Test" Challenge campaign kicked off on Tuesday. The department partnered with the Center for Disease Control and the National Institute of Health to provide county residents with free, rapid, at-home COVID-19 test kits. Source: WRCBtv
Wearable patch sends simultaneous signals of health
Science Highlights
April 6, 2021
epidermal patch attached to forearm to monitor blood pressure and metabolites
NIBIB-funded engineers have developed a flexible epidermal patch that can simultaneously and continuously monitor cardiac output and metabolic levels of glucose, lactate, caffeine, or alcohol. The patch is a major step towards continuous non-invasive health monitoring.